WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Taysha Gene Therapies earnings were -$86.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TSHA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$21.5M, up 14.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TSHA reported annual earnings of -$89.3M, with -20% growth.

TSHA earnings history

Current Revenue
$7.2M
Current Earnings
-$86.8M
Current Profit Margin
-1,201.1%

TSHA Return on Equity

Current Company
-107%
Current Industry
-60.2%
Current Market
31.4%
TSHA's Return on Equity (-107%)... subscribe to Premium to read more.
High Return on Equity Performance

TSHA undefined

Current Company
-51.1%
Current Industry
-2.5%
TSHA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TSHA announces earnings.

TSHA undefined

Current Company
-74.84%
Current Industry
5.8%
TSHA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TSHA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TSHA-$84.24M-$86.77MN/A-$0.34
CAPR-$53.57M-$55.06MN/A-$1.37
BCYC-$200.61M-$203.22MN/A-$3.14
MNMD-$75.18M-$77.63MN/A-$0.95
ZVRA-$60.30M-$91.99MN/A-$1.92
View Top Biotech Stocks

Taysha Gene Therapies Earnings Reports & History FAQ

What were Taysha Gene Therapies's earnings last quarter?

On TSHA's earnings call on Invalid Date, Taysha Gene Therapies (NASDAQ: TSHA) reported Q1 2025 earnings per share (EPS) of -$0.08, up 20% year over year. Total TSHA earnings for the quarter were -$21.53 million. In the same quarter last year, Taysha Gene Therapies's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.

Is Taysha Gene Therapies profitable or losing money?

As of the last Taysha Gene Therapies earnings report, Taysha Gene Therapies is currently losing money. Taysha Gene Therapies's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$86.77 million, a 26.47% decrease year over year.

What was TSHA's earnings growth in the past year?

As of Taysha Gene Therapies's earnings date in Invalid Date, Taysha Gene Therapies's earnings has grown year over year. TSHA earnings in the past year totalled -$86.77 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.